Search

Your search keyword '"Brooks, G"' showing total 2,316 results
Start Over Author "Brooks, G"
2,316 results on '"Brooks, G"'

105. Proceedings of the Twelfth Annual Meeting. Society for the Study of Amphibians and Reptiles

Author

Schmid, William D., Kluge, Arnold G., Nelson, Craig E., Pettus, David, Post, Douglas D., Hess, John B., Tordoff, Walter, Taylor, Edward H., Huheey, James E., Harrison, Julian R., Gordon, Robert E., Minton, Sherman A., Crawford, F. T., Gross, Guenter W., Jenssen, Thomas A., Lang, Jeffrey W., Brooks, G. R., Black, Jeffrey H., Schaaf,, Raymond T., Adler, Kraig, Thurow, Gordon R., Brandon, Ronald A., Barthalmus, George T., Briggs, Jeffrey L., and Storm, Robert M.

Published
1969

106. EXPRESS: real-time brand reputation tracking using social media

Author

Rust, RT, Rand, W, Huang, M-H, Stephen, A, Brooks, G, and Chabuk, T

Abstract

How can we know what stakeholders think and feel about brands in real-time and over time? Most brand reputation measures are at the aggregate level (e.g., the Interbrand “Best Global Brands” list) or rely on customer brand perception surveys on a periodical basis (e.g., the Y&R Brand Asset Valuator). To answer this question, brand reputation measures must capture the voice of the stakeholders (not just ratings on brand attributes), must reflect important brand events in real-time, and must connect to a brand’s financial value to the firm. This paper develops a new social media-based brand reputation tracker by mining Twitter comments for the world’s top 100 brands using Rust-Zeithaml-Lemon’s value-brand-relationship framework, on a weekly, monthly, and quarterly basis. The paper demonstrates that brand reputation can be monitored in real-time and longitudinally, managed by leveraging the reciprocal and virtuous relationships between the drivers, and connected to firm financial performance. The resulting measures are housed in an online longitudinal database and may be accessed by brand reputation researchers.

Published
2021

108. Olfactory Conditioning in the Third Instar Larvae of Drosophila melanogaster Using Heat Shock Reinforcement

Author

Khurana, Sukant, Robinson, Brooks G., Wang, Zihe, Shropshire, William C., Zhong, Allen C., Garcia, Laura E., Corpuz, Jonathan, Chow, Jonathan, Hatch, Michael M., Precise, Eric F., Cady, Amanda, Godinez, Ryan M., Pulpanyawong, Terapat, Nguyen, Andrew T., Li, Wen-ke, Seiter, Max, Jahanian, Kambiz, Sun, Jeffrey C., Shah, Ruchita, Rajani, Sunaina, Chen, William Y., Ray, Sofia, Ryazanova, Natalie V., Wakou, Dorah, Prabhu, Rohith K., and Atkinson, Nigel S.

Published
2012
Full Text
View/download PDF

112. Development of Novel AAV-Based Gene Therapy for Cardiac Disease

Author

Whittlesey, K., primary, Brooks, G., additional, Szymanski, P., additional, Beliakoff, G., additional, Nye, J., additional, Croze, R., additional, Schmitt, C., additional, Bickta, J., additional, Barglow, K., additional, Kotterman, M., additional, Francis, P., additional, Schaffer, D., additional, and Kirn, D., additional

Published
2021
Full Text
View/download PDF

114. A low concentration of ethanol impairs learning but not motor and sensory behavior in Drosophila larvae.

Author

Brooks G Robinson, Sukant Khurana, Jascha B Pohl, Wen-ke Li, Alfredo Ghezzi, Amanda M Cady, Kristina Najjar, Michael M Hatch, Ruchita R Shah, Amar Bhat, Omar Hariri, Kareem B Haroun, Melvin C Young, Kathryn Fife, Jeff Hooten, Tuan Tran, Daniel Goan, Foram Desai, Farhan Husain, Ryan M Godinez, Jeffrey C Sun, Jonathan Corpuz, Jacxelyn Moran, Allen C Zhong, William Y Chen, and Nigel S Atkinson

Subjects
Medicine, Science
Abstract

Drosophila melanogaster has proven to be a useful model system for the genetic analysis of ethanol-associated behaviors. However, past studies have focused on the response of the adult fly to large, and often sedating, doses of ethanol. The pharmacological effects of low and moderate quantities of ethanol have remained understudied. In this study, we tested the acute effects of low doses of ethanol (∼7 mM internal concentration) on Drosophila larvae. While ethanol did not affect locomotion or the response to an odorant, we observed that ethanol impaired associative olfactory learning when the heat shock unconditioned stimulus (US) intensity was low but not when the heat shock US intensity was high. We determined that the reduction in learning at low US intensity was not a result of ethanol anesthesia since ethanol-treated larvae responded to the heat shock in the same manner as untreated animals. Instead, low doses of ethanol likely impair the neuronal plasticity that underlies olfactory associative learning. This impairment in learning was reversible indicating that exposure to low doses of ethanol does not leave any long lasting behavioral or physiological effects.

Published
2012
Full Text
View/download PDF

115. Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes

Author

Brooks,G Daniel and Brooks,G Daniel

Abstract

G Daniel Brooks The Asthma and Allergy Center, Bellevue, NE, USACorrespondence: G Daniel BrooksThe Asthma and Allergy Center, 3503 Samson Way, Suite 108, Bellevue, NE 68123, USATel +1-402-592-2055Fax +1-402-592-2419Email gdbrooks@asthmaandallergycenter.comAbstract: Uncontrolled asthma continues to be a problem for many patients with moderate-to-severe allergic asthma. Dupilumab, which blocks the receptors for interleukin-4 and interleukin-13, has been effective in reducing asthma exacerbations, improving forced expiratory volume in one second (FEV1), and reducing oral corticosteroid use. When selecting patients for dupilumab, it is important to consider entry criteria for the original studies, subgroups that have responded best, and the presence of comorbid diseases that may also respond to dupilumab. Factors that were considered when selecting patients likely to respond to dupilumab in asthma studies include: failure of moderate or high dose inhaled steroids in combination with an additional controller medication, baseline FEV1 reversibility of 12% or greater, and Asthma Control Questionnaire > 1.5. The baseline characteristics that predicted a better response to dupilumab included blood eosinophils > 150 cells/mm3 and fractional exhaled nitric oxide > 25 parts per billion. Comorbidities that may also respond to treatment with dupilumab include atopic dermatitis, chronic rhinosinusitis, and allergic rhinitis. A combination of these factors should be considered when selecting the patients most likely to benefit from dupilumab.Keywords: allergic asthma, dupilumab, eosinophils, nitric oxide, comorbidity

Published
2020

140. A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype

Author

Weijden, Marlous C.M., primary, Rodriguez‐Contreras, Dayana, additional, Delnooz, Cathérine C.S., additional, Robinson, Brooks G., additional, Condon, Alec F., additional, Kielhold, Michelle L., additional, Stormezand, Gilles N., additional, Ma, Kai Yu, additional, Dufke, Claudia, additional, Williams, John T., additional, Neve, Kim A., additional, Tijssen, Marina A.J., additional, and Verbeek, Dineke S., additional

Published
2020
Full Text
View/download PDF

147. Revised5 Report on the Algorithmic Language Scheme

Author

Abelson, H., Dybvig, R.K., Haynes, C.T., Rozas, G.J., Adams, IV, N.I., Friedman, D.P., Kohlbecker, E., Steele, Jr., G.L., Bartley, D.H., Halstead, R., Oxley, D., Sussman, G.J., Brooks, G., Hanson, C., Pitman, K.M., and Wand, M.

Published
1998
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results